Hybrids of 1-deoxynojirimycin (DNJ) and aryl-1,2,3-triazole have been synthesized with a view to identifying an inhibitor of both alpha-glucosidase and methionine aminopeptidase 2 (MetAP2). One compound was a potent inhibitor of alpha-glucosidase at both the enzyme and cellular level, and this agent also inhibited bovine aortic endothelial cell (BAEC) growth and tube formation.
The anti-proliferative activity of this hybrid is due to its ability to induce cell-cycle arrest in the G(1) phase.
The novel agent caused a reduction in the expression of cyclin D1 but did not promote apoptosis or inhibit the phosphorylation of ERK1/2. These observations indicate that its mechanism of action is distinct from fumagillin and its analogues, which inhibit MetAP2. Stress-fibre assembly in BAECs was abolished by the novel agent indicating that the inhibition of BAEC tube formation observed is partially a result of a reduction in cell motility.
2008-06-13
Eng.
Bioorganic & medicinal chemistry
UCD School of Biomolecular and Biomedical Science and the UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.
Bioorg Med Chem. 2008 Jun;16(12):6333-7
© Galenicom 1999-2013